Reduced neutralization sensitivity of monoclonal antibodies and convalescent and vaccinated sera against SARS-CoV-2 B.1.617.2 India variant was confirmed. Moreover, it was found that the sera from SARS-CoV-2 B.1.351 and P.1 variants infected individuals were less effective to neutralize the B.1.617.2 variant.
Monday, July 12, 2021
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment